These powerful, high-capacity portable batteries are the best ones when laptop charging is a priority. All have at least 20,000 mAh, enough to charge most laptops twice. Toss the right laptop power ...
On Tuesday, the AI company Recursive Superintelligence announced a $410 million compute deal with Amazon Web Services. The company, which emerged from stealth in May with $650 million in funding, is ...
Anthropic is in very preliminary talks to lease computing power from Meta. The New York Times reported that a potential deal was being discussed worth about $10 billion. The talks come weeks after ...
The artificial intelligence boom in the United States is being matched by a data center building boom. There are more than 3,000 data centers in the U.S. and another 1,500 in development, according to ...
Reflection AI, a U.S. startup vying to develop open models, has signed a $1 billion compute deal with European AI infrastructure company Nebius. Nebius, a company spun out of Russian tech giant Yandex ...
Kalshi Inc. has created a tool that plots the future price of computing power, joining the ranks of exchange and index operators attempting to build markets around the commodity powering artificial ...
Sunrun’s building a ‘nationwide compute network’ that will run AI from small compute nodes in customers’ homes. Sunrun’s building a ‘nationwide compute network’ that will run AI from small compute ...
Meta Platforms (META) shares jumped more than 10% in early trading on Wednesday after Bloomberg reported it is building a cloud business for excess artificial intelligence compute. The company is ...
Recursion Pharmaceuticals operates as a TechBio company, using its proprietary Recursion OS to automate biological experiments and analyze them with artificial intelligence. The company generates vast ...
This is part of a series of columns about the viability of the American university system. In the previous installment of this series on the future of higher education, I talked with professors about ...
Recursion Pharmaceuticals is trying to solve a serious problem. Even with technological improvements, the time and costs required to develop brand-new drugs have increased in recent decades. It can ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results